Skip to main
IRTC
IRTC logo

iRhythm Technologies (IRTC) Stock Forecast & Price Target

iRhythm Technologies (IRTC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 46%
Buy 38%
Hold 15%
Sell 0%
Strong Sell 0%

Bulls say

iRhythm Technologies Inc. is experiencing positive momentum in its financial outlook, driven by an increase in expected revenue, which reflects both volume and pricing trends in its business. The company's innovative Zio System, which integrates wearable biosensors with advanced data analytics, positions it effectively within the digital healthcare market, thereby enhancing its competitive edge and diagnostic efficiency for arrhythmias. Additionally, the adjustment of the price target indicates growth potential as it incorporates a rising mean comparable group multiple, underlining the firm's strong positioning in the ambulatory cardiac monitoring sector.

Bears say

iRhythm Technologies Inc. faces significant challenges due to heightened competition in the ambulatory cardiac monitoring market, where rival companies may introduce more effective solutions, potentially diminishing iRhythm's commercial prospects. The company also risks adverse financial impacts from fluctuating public health insurance coverage and changes in reimbursement rates from both CMS and third-party payors, which could hinder the adoption and profitability of its Zio service. Additionally, iRhythm has a troubling history of net losses, and its dependence on physician adoption of its services further compounds its financial instability and uncertainty.

iRhythm Technologies (IRTC) has been analyzed by 13 analysts, with a consensus rating of Buy. 46% of analysts recommend a Strong Buy, 38% recommend Buy, 15% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About iRhythm Technologies (IRTC) Forecast

Analysts have given iRhythm Technologies (IRTC) a Buy based on their latest research and market trends.

According to 13 analysts, iRhythm Technologies (IRTC) has a Buy consensus rating as of Oct 28, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $184.85, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $184.85, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

iRhythm Technologies (IRTC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.